The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

This Morning hosts Alison Hammond and Dermot O'Leary will front the daytime programme for an entire week from October 28.

Hindustan Unilever’s (HUL’s) board of directors decided in a meeting held on Wednesday to separate the ice cream business. In September, the board constituted a committee of independent directors to ...

Analysts expect the discontinuation of GlaxoSmithKline Consumer Healthcare's distribution agreement for over-the-counter (OTC) products on November 8, 2023, to put pressure on operating income.

The update on the GSK-partnered prospect sent Wave’s share price up 63% to almost $14 despite coinciding with news that Takeda has axed a deal for another asset. The ongoing phase 1b/2a study is ...

So grab that cup of stimulation and get started. Our flavor today is Irish cream, for those tracking our habits. Now, though, the time has come to get busy. So please grab your own cup and dig in ...

GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work of a team ...

GSK is also seeking damages to compensate for the alleged infringement as well as a “compulsory ongoing licensing fee” for the claimed technologies. “Moderna has reaped billions of dollars in revenue ...

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...

Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA vaccine-delivery technology, the company said in a pair of federal lawsuits.

The Moderna lawsuits echo similar claims made by GSK when it sued Pfizer and BioNTech for allegedly infringing upon the company’s mRNA patents back in April. At the time, Pfizer voiced ...

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...